Next Financial Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Next Financial Group’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$1K	–	2127
2020 Q1	$1K	Hold	100	–	–	﹤0.01%	2082
2019 Q4	$2K	Hold	100	–	–	﹤0.01%	2239
2019 Q3	$3K	Hold	100	–	–	﹤0.01%	2075
2019 Q2	$3K	Buy	+100	New	+$3.14K	﹤0.01%	2074
2019 Q1	–	Sell	-100	Closed	-$2K	–	2248
2018 Q4	$2K	Buy	+100	New	+$2.06K	﹤0.01%	1799
2017 Q4	–	Sell	-100	Closed	-$5K	–	1608
2017 Q3	$5K	Hold	100	–	–	﹤0.01%	1446
2017 Q2	$6K	Sell	100 -100	-50%	-$4K	﹤0.01%	1516
2017 Q1	$8K	Hold	200	–	–	﹤0.01%	1384
2016 Q4	$4K	Hold	200	–	–	﹤0.01%	2038
2016 Q3	$5K	Buy	+200	New	+$4.7K	﹤0.01%	1956

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Next Financial Group's PTLA Position: Q2 2020 in Review

Next Financial Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 100 shares — an estimated $1K sold.

Next Financial Group first reported a position in PTLA in Q3 2016 and held it in 10 quarters. The position peaked at $8K in Q1 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Next Financial Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Next Financial Group sold 100 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1K.
Next Financial Group first reported a position in Portola Pharmaceuticals, Inc. in Q3 2016 and held it in 10 quarters.
Next Financial Group's Portola Pharmaceuticals, Inc. position peaked at $8K in Q1 2017.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Next Financial Group's 13F filing for Q2 2020, filed 24 Jul 2020.